YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Cytotoxic Effects of an Oncolytic Adenoviral Vector AdLPCDIRESE1A in Hepatocellular Carcinoma Cells

암세포 용해성 AdLPCDIRESE1A 벡터의 간암 세포독성효과

  • Received : 2011.02.10
  • Accepted : 2011.02.16
  • Published : 2011.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

The replication competent adenoviral vector (AV), AdLPCDIRESE1A was generated and reported previously to have cytotoxic effects in some cell lines. In AdLPCDIRESE1A, the expression of cytosine deaminse (CD) and E1A genes are under the control of tumor-specific L-plastin promoter. CD enzyme can deaminate the nontoxic prodrug 5-fluorocytosine (5-FC) to the toxic 5-fluorouracil (5-FU). E1A gene is essential for viral replication. Primary liver cancer, most of which is hepatocellular carcinoma (HCC), is the third common leading cancer in Korea. Thus, we have conducted in vitro preclinical study to evaluate effectiveness of AdLPCDIRESE1A on HCC. The efficacy of cytotoxicity was measured by generation of cytopathic effect (CPE) and cell counting. We infected HepG2 cells with various MOI of vector alone or concurrent with 5-FC. Exposure of cells to AdLPCDIRESE1A generated a significant cytotoxic effect as compared to the control. Almost 83% of the cell had manifested the characteristic cytotoxic effect on day 9 after infection of cells with 10 MOI of vector. We also observed the additive cytotoxic effects when AdLPCDIRESE1A vector had been coadministrated with 5-FC. The results suggest that the use of AdLPCDIRESE1A/5FC may be value in treatment of liver cancer. Further animal studies are needed for clinical trial.

Keywords

References

  1. Chung, I. : Cancer gene therapgy: history and major developments. J. Toxicol. Pub. Health 19, 247 (2003).
  2. Chung, I., Schwartz, P. E., Crystal, R. G., Pizzorno, G., Leavitt, J. L. and Deisseroth, A. B. : Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Ther. 6, 99 (1999). https://doi.org/10.1038/sj.cgt.7700017
  3. Chung, I. and Deisseroth, A. B. : Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit : generation and functional test. Arch. Pharm. Res. 27, 633 (2004). https://doi.org/10.1007/BF02980163
  4. Lin, C.-S., Park, T., Chen, Z. P. and Leavitt, J. L. : Human plastin genes. J. Biol. Chem. 268, 2781 (1993).
  5. Lin, C.-S., Chen, Z. P., Park, T., Ghosh, K. and Leavitt, J. : Characterization of the human L-plastin gene promoter in normal and neoplastic cells. J. Biol. Chem. 268, 2793 (1993).
  6. Peng, X. Y., Won, J. H., Rutherford, T., Fujii, T., Zelterman, D., Pizzorno, G., Sapi, E., Leavitt, J., Kacinski, B., Crystal, R., Schwartz, P. and Deisseroth, A. : The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res. 61, 4405 (2001).
  7. Chung, I. : Chemosensitization of human ovarian carcinoma cells by a recombinat adenoviral vector containing L-plastin promoter fused to cytosine deaminase transcription unit. J. Applied Pharmacol. 13, 143 (2005).
  8. Zhang, L., Akbulut, H., Tang, Y., Peng, X., Pizzorno, G., Sapi, E., Manegold, S. and Deisseroth, A. : Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma. Mol. Ther. 6, 386 (2002). https://doi.org/10.1006/mthe.2002.0680
  9. Chung, I. : Cytolytic Effects of an adenoviral vector containing L-plastin promoter regulated E1A in hepatocellular carcinoma cells. J. Applied Pharmacol. 14, 148 (2006).
  10. Akbulut, H., Zhang, L., Tang, Y. and Deisseroth, A. : Cytotoxic effect of replication-competent adenoviral vectors carrying Lplastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther. 10, 388 (2003). https://doi.org/10.1038/sj.cgt.7700579
  11. Akbulut, H., Tang, Y., Maynard, J., Zhang, L., Pizzorno, G. and Deisseroth, A. : Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms. Clin. Cancer Res. 10, 7738 (2004). https://doi.org/10.1158/1078-0432.CCR-04-0490
  12. Graham, F. L. and Prevec, L. : Manipulation of adenovirus vectors, Methods in molecular biology, Vol. 7, pp. 109-128. E. J. Murray, The Human Press Inc., Clifton, NJ (1991).
  13. Alemany, R., Balagu, C. and Curiel, D. T. : Replicative adenoviruses for cancer therapy. Nature Biotechnol. 18, 723 (2000). https://doi.org/10.1038/77283
  14. Heise, C. and Kirn, D. H. : Replication-selective adenoviruses as oncolytic agents. J. Clin. Invest. 105, 847 (2000). https://doi.org/10.1172/JCI9762
  15. Jung, K., Kim, S., Lee, K., Kim, C. and Chung, I. : Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells. Arch. Pharm. Res. 30, 770 (2007). https://doi.org/10.1007/BF02977641